Bactobio is a London-based biotechnology company that uses breakthroughs in genomics, machine learning and bioengineering to culture the 99% of microbes that have previously been unculturable. Our exclusive access to nature’s greatest bioresource allows us to unlock novel chemistries that have evolved to be effective, specific and biodegradable. Our first targets are to discover novel antibiotics against the worst bacterial infections and help make plant protection sustainable.
| Website | http://bacto.bio |
| Employees | 51 (1 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Microbial Cultivation, Microbial Genomics, Microbial Research, Genome Engineering, Genomics Research, Microbial Engineering, Microbial Ecology, Biotechnology, Bioengineering, Metagenomics, Biotechnology Solutions, Machine Learning, Biomanufacturing, Precision Fermentation, Synthetic Biology, Drug Discovery, Bioprocess Development, Sustainable Biomanufacturing |
| Competitors | Zymergen, Inc., Amgen, Codexis, Inc., Novozymes, Biocatalysts Ltd, Evonik, BASF, AstraZeneca, Geno, DuPont +24 more (view full list) |
Looking for a particular Bactobio employee's phone or email?
Daniel Hansen is the Chief Executive Officer and Co-Founder of Bactobio.
1 people are employed at Bactobio.